Clinical Trials Logo

Familial Amyloid Neuropathies clinical trials

View clinical trials related to Familial Amyloid Neuropathies.

Filter by:
  • None
  • Page 1

NCT ID: NCT02595983 Completed - ATTR Amyloidosis Clinical Trials

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Start date: October 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the safety and effectiveness of revusiran (ALN-TTRSC) in adults with transthyretin-mediated amyloidosis (ATTR), whose disease has continued to worsen after liver transplantation. Dosing has been discontinued; patients are being followed-up for safety.